Pardes Biosciences
Sally-Anne T. has a diverse work experience spanning multiple industries. Sally-Anne is currently working at Pardes Biosciences as the Director of SEC Reporting and Technical Accounting. Prior to this, they were a Manager of SEC Reporting at Clover Health and worked as a Senior SEC Reporting & Analysis professional at WELLS FARGO & COMPANY.
In 2019, Sally-Anne served as a Financial Controller at NextEra Energy, Inc., where they managed renewable energy portfolios and handled tasks such as budgeting and forecasting.
Before that, they worked at Workiva as a Professional Services Manager, overseeing client projects. Prior to that, they held the role of Financial Analyst at First Citizens Bank. Sally-Anne began their career at Univision Communications Inc. as a Telecom Expense Analyst before being promoted to Telecom Expense Manager. Overall, Sally-Anne has demonstrated expertise in SEC reporting, financial analysis, and project management throughout their career.
Sally-Anne T. pursued their education at the University of Florida, where they obtained a Bachelor of Science (B.S.) degree in Accounting from 2006 to 2008. Sally-Anne then continued their academic journey at the same institution, completing their Masters of Accounting degree in Accounting from 2008 to 2009. In addition to their academic qualifications, Sally-Anne T. also obtained the Certified Public Accountant certification from the North Carolina State Board of CPA Examiners in October 2014.
This person is not in any offices
Pardes Biosciences
Pardes Biosciences is an agile biopharmaceutical company committed to solving some of the world’s most pressing public health challenges. Pardes leverages structure-based drug design and a tunable, reversible covalent chemistry platform for novel drug discovery.